Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

585

currently held

Exits tracked

189

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Save searches, build watchlists, pick up where you left off. Free, no credit card.

Start free

740 companies matching · Page 5 of 15

Company	Sector	Geo	Investor	Entry	Status
Pretzel Therapeutics CIC Fund II	Biotech	USA	Cambridge Innovation Capital	2021	Active
Quell Therapeutics SV7 Impact Medicine Fund	Biotech	United Kingdom	SV Health Managers	2021	Active
Refoxy Pharma NRW.Venture	Biotech	Germany	NRW.BANK	2024	Active
Refoxy Pharmaceuticals Boehringer Ingelheim Venture Fund	Biotech	Germany	Boehringer Ingelheim Venture Fund	2020	Active
Rhizocore Technologies Nucleus Capital I	Biotech	United Kingdom	Nucleus Capital	2022	Active
Scripta YZR Capital Fund I	Biotech	United Kingdom	YZR Capital	2025	Active
TES Pharma Indaco BIO	Biotech	Italy	Indaco Venture Partners SGR	2024	Active
TRIMTECH Therapeutics CIC Fund II	Biotech	UK	Cambridge Innovation Capital	2023	Active
Umlaut.bio HTGF IV	Biotech	Germany	High-Tech Gruenderfonds (HTGF)	2024	Active
Vytrus Biotech Zamit Capital	Biotech	Spain	GVC Gaesco Alternative Investments	2019	Active
2invest AG (formerly 4basebio AG) Deutsche Balaton Evergreen Holding (Balance Sheet)	Biotech	Germany	Deutsche Balaton Aktiengesellschaft	2020	Active
300K Solutions ADE Capital Sodical	Biotech	Spain	Sodical	2024	Active
3P Biovian Sodena Direct	Biotech	Spain	Sodena	2007	Active
4basebio PLC Deutsche Balaton Evergreen Holding (Balance Sheet)	Biotech	United Kingdom	Deutsche Balaton Aktiengesellschaft	2021	Active
4TEEN4 Pharmaceuticals NRW.Venture	Biotech	Germany	NRW.BANK	2019	Active
65Lab Leaps by Bayer	Biotech	Singapore	Leaps by Bayer	2023	Active
AAVantgarde XGEN Venture Life Sciences Fund	Biotech	Italy	XGen Venture SGR	2025	Active
Accipiter Biosciences Columbus Life Sciences Fund IV	Biotech	United States	Columbus Venture Partners	2025	Active
AcousticaBio Vento Fund I	Biotech	United States	Vento	2023	Active
Adaptam Therapeutics Criteria Bio Ventures	Biotech	Spain	Caixa Capital Risc	2025	Active
Addition Therapeutics Abingworth Bioventures IX	Biotech	US	Abingworth	2025	Active
Adicet Bio Abingworth Bioventures VII	Biotech	US	Abingworth	2021	Active
Adrenomed Wellington Partners Life Sciences	Biotech	Germany	Wellington Partners	2018	Active
Adrenomed AG Fruehphasen- und Wachstumsfonds Brandenburg	Biotech	Germany	Brandenburg Kapital	2020	Active
AELIX Therapeutics Ysios BioFund II Innvierte	Biotech	ES	Ysios Capital Partners	2016	Active
Aeovian Pharmaceuticals Apollo Health Ventures Fund I	Biotech	United States	Apollo Health Ventures	2019	Active
AFFiRiS MIG Fonds 5	Biotech	Austria	MIG Capital	2006	Active
Affirma Bio Nara Health Capital	Biotech	Spain	Nara Capital Partners	2024	Active
Aglaris CRB Bio II	Biotech	United Kingdom	CRB Health Tech	2016	Active
AiCuris Athos Evergreen Life Sciences	Biotech	Germany	Athos	2006	Active
Akribion Therapeutics HTGF IV	Biotech	Germany	High-Tech Gruenderfonds (HTGF)	2025	Active
Akribion Therapeutics GmbH Technologiefonds Hessen	Biotech	Germany	BMH Beteiligungsmanagement Hessen	2024	Active
AL-S Pharma AG TVM Life Science Innovation	Biotech	Switzerland	TVM Capital Life Science	2016	Active
Alchemab Therapeutics SV7 Impact Medicine Fund	Biotech	UK	SV Health Managers	2019	Active
Alentis HTGF III	Biotech	Switzerland	High-Tech Gruenderfonds (HTGF)	2019	Active
Aleta Biotherapeutics Columbus Life Sciences Fund IV	Biotech	United States	Columbus Venture Partners	2024	Active
Allogenetics GmbH NBank Capital Beteiligungsfonds	Biotech	Germany	NBank Capital	2024	Active
Allogenica Sorbonne Venture	Biotech	France	Aloe Private Equity	2022	Active
ALLOX Sabadell Asabys Health Innovation Investments II	Biotech	Spain	Asabys Partners	2023	Active
Alveogene Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2023	Active
AmacaThera Inveready Biotech III	Biotech	Canada	Inveready Asset Management	2020	Active
Amphista Therapeutics Dementia Discovery Fund	Biotech	UK	SV Health Managers	2022	Active
Amply Co-Fund NI	Biotech	United Kingdom	Clarendon Fund Managers	2022	Active
Amply Discovery Ltd QUBIS Ltd	Biotech	UK	Qubis	2021	Active
AMR Bio EMV Capital Evergreen Fund	Biotech	UK	EMV Capital	2025	Active
AnaBios Principia III - Health	Biotech	United States	Principia SGR	2016	Active
Angarus Therapeutics Nara Health Capital	Biotech	Spain	Nara Capital Partners	2022	Active
AntalGenics Inveready Biotech II	Biotech	Spain	Inveready Asset Management	2017	Active
Aptarion Biotech Bioventure Club Deals	Biotech	Germany	Bioventure Management	2017	Active
Aramune Technologies Ltd QUBIS Ltd	Biotech	UK	Qubis	2021	Active